Stryker (SYK) announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, a privately held medical technology company developing a next-generation intravascular lithotripsy platform designed to treat calcified peripheral arterial disease. This transaction is subject to customary closing conditions. Stryker and AVS will continue to operate as separate entities and proceed with business as usual until the transaction closes.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker price target lowered to $397 from $412 at BTIG
- Stryker initiated with an Outperform at Leerink
- William Blair med tech analyst holds an analyst/industry conference call
- Citi cuts Stryker target, opens ‘downside 90-day catalyst watch’
- Stryker price target lowered to $365 from $400 at Evercore ISI
